PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

FDA places hold on INmune Bio’s Alzheimer’s trial

INmune Bio has some explaining to do to the FDA before the company can continue with its trial of XPro, an investigational new drug intended to treat Alzheimer’s.

While the FDA has yet to make a statement about it or send the official hold letter to the company, INmune announced that the agency requested additional information on the Chemistry Manufacturing Controls of the new drug, XPro1595.

Xpro1595 is a next-generation tumour necrosis factor (TNF) inhibitor that acts differently than currently available TNF inhibitors in that it neutralizes soluble TNF (sTNF), without affecting trans-membrane TNF or other receptors. The drug works could alleviate Alzheimer’s symptoms by decreasing neuroinflammation and improving cognitive function.

The FDA said they will provide an official letter — placing the company’s IND for its phase 2 U.S. trial on clinical hold — to INmune in the next month or so. The company also announced that the phase 2 trial of XPro remains open in Australia and continues to enrol patients.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026